Limosilactobacillus fermentum CQPC04 could inhibit oxidative stress and inflammation in mice with colitis, and its mechanism of it is to regulate the NF-κB signaling pathway (Zhou et al., 2019). This evidence concerns the gene NFKB1 and colitis.